Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo
萨拉卡替尼的 Src 抑制可在体外和体内逆转 ER 阳性卵巢癌模型中的氟维司群耐药性
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-12-1257
Fiona Simpkins, Pedro Hevia-Paez, Jun Sun, Wendy Ullmer, Candace A Gilbert, Thiago da Silva, Ali Pedram, Ellis R Levin, Isildinha M Reis, Brian Rabinovich, Diana Azzam, Xiang-Xi Xu, Tan A Ince, Ji-Yeon Yang, Roel G W Verhaak, Yiling Lu, Gordon B Mills, Joyce M Slingerland